The CDM is directly (intratumoral) injected into pancreatic cancers in orthotopic models through invasive approach, and cancer tissue is locally irradiated by visible light to promote the caspase-3 overexpression by inducing apoptosis, resulting in subsequent release of MMAE (Figure 1c). Here, CASP3 is linked to pancreatic neoplasm.